Grocery stores sue Abbott over Norvir pricing
Executive Summary
Safeway, Walgreens, Kroger, New Albertson's and American Sales Company file an antitrust complaint against Abbott Oct. 26 claiming that its 400 percent Norvir price hike in 2003 restricted competition in the market for protease inhibitor boosters. Abbott increased the wholesale price of Norvir from $205.74 to $1,028.71 but did not increase the price of its Kaletra, which incorporates Norvir. The price hike drastically increased the price of competing regimens using Norvir to boost PIs, the complaint says, forcing plaintiffs to pay higher prices. The Prescription Access Litigation filed a similar class action antitrust suit against Abbott in 2004...